Sustainability is now a real purchasing factor in life science, and researchers are watching which vendors deliver. Credible progress translates directly into loyalty and willingness to pay a premium. See what your customers are really…

The push toward real‑time verification and pre‑analytical quality control was visible across SLAS 2026, reflected in new on‑deck sensing modules and instrumentation designed to validate runs as they occur in real-time. The full extent of new products and themes was…

Kalorama Information estimates that the global market for sepsis diagnostics reached approximately $1.3 billion in 2025, reflecting the enormous clinical and economic weight sepsis places on global healthcare. Yet despite steady growth and widespread use of…

For decades, diagnostic imaging manufacturers have anchored their growth strategies to clinical demand, capital cycles, and incremental modality innovation. However, a quieter (and potentially more disruptive) shift is now underway upstream in the life sciences.…

The NIH’s growing emphasis on New Approach Methodologies (NAMs) marks a significant change in how biomedical research, particularly drug development, is being conducted. Prompted by legislative changes, evolving regulatory guidance, and long-standing concerns about the…